IP Library Assignment 056411/0382
Patent Assignment
Reel/Frame 056411/0382

Assignment of Assignor's Interest

Recorded: 2021-06-02 Pages: 7
Assignors
DUDLEY, MICHAEL N
Executed: 2009-12-01
TSIVKOVSKI, RUSLAN Y
Executed: 2009-11-18
GRIFFITH, DAVID C
Executed: 2009-11-18
RODNY, OLGA
Executed: 2009-11-18
Assignee
MPEX PHARMACEUTICALS, INC.
11535 SORRENTO VALLEY ROAD, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (2)
Topical Use of Levofloxacin for Reducing Lung Inflammation
Application: 15/729,930 →
Publication: US 2018/0085462
Topical Use of Levofloxacin for Reducing Lung Inflammation
Application: 17/240,273 →
Publication: US 2022/0080047
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement May 22, 2019
From: HORIZON ORPHAN LLC
To: CITIBANK, N.A.
Reel/Frame 050253/0855 →
Assignment of Assignor's Interest May 28, 2021
From: MPEX PHARMACEUTICALS, INC.
To: TRIPEX PHARMACEUTICALS, LLC
Reel/Frame 056383/0920 →
Assignment of Assignor's Interest May 28, 2021
From: TRIPEX PHARMACEUTICALS, LLC
To: RAPTOR PHARMACEUTICALS INC.
Reel/Frame 056422/0235 →
Change of Name May 28, 2021
From: RAPTOR PHARMACEUTICALS INC.
To: HORIZON ORPHAN LLC
Reel/Frame 056424/0102 →
Release of Security Interest Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC)
Reel/Frame 065154/0014 →
Merger and Change of Name Dec 21, 2023
From: HORIZON THERAPEUTICS, LLC; HORIZON ORPHAN LLC
To: HORIZON THERAPEUTICS U.S. HOLDING LLC
Reel/Frame 065928/0608 →